JP2010516817A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010516817A5 JP2010516817A5 JP2009548391A JP2009548391A JP2010516817A5 JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5 JP 2009548391 A JP2009548391 A JP 2009548391A JP 2009548391 A JP2009548391 A JP 2009548391A JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- formula
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 7
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000003648 hair appearance Effects 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 230000003752 improving hair Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- -1 p-t-butylphenyl Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88741507P | 2007-01-31 | 2007-01-31 | |
| US60/887,415 | 2007-01-31 | ||
| PCT/US2008/052318 WO2008094912A2 (en) | 2007-01-31 | 2008-01-29 | Substituted gamma lactams as therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010516817A JP2010516817A (ja) | 2010-05-20 |
| JP2010516817A5 true JP2010516817A5 (enExample) | 2011-03-10 |
| JP5566692B2 JP5566692B2 (ja) | 2014-08-06 |
Family
ID=39639429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548391A Expired - Fee Related JP5566692B2 (ja) | 2007-01-31 | 2008-01-29 | 治療薬としての置換ガンマラクタム類 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7960381B2 (enExample) |
| EP (1) | EP2121672B1 (enExample) |
| JP (1) | JP5566692B2 (enExample) |
| KR (1) | KR101561706B1 (enExample) |
| CN (1) | CN101595106B (enExample) |
| AU (1) | AU2008210559B2 (enExample) |
| BR (1) | BRPI0808377B8 (enExample) |
| CA (1) | CA2676291C (enExample) |
| MX (1) | MX2009008039A (enExample) |
| NZ (1) | NZ578698A (enExample) |
| WO (1) | WO2008094912A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8377984B2 (en) * | 2008-01-29 | 2013-02-19 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
| AU2009239381A1 (en) * | 2008-04-24 | 2009-10-29 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
| EP2291368B1 (en) * | 2008-04-24 | 2012-12-19 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
| CA2722456A1 (en) | 2008-04-24 | 2009-10-29 | Allergan, Inc. | Substituted arylcyclopentenes as prostaglandin ep2 agonists |
| BRPI0912342A2 (pt) * | 2008-05-09 | 2015-10-06 | Allergan Inc | tiazolidinonas, oxazolidinonas substituídas terapêuticas, e compostos relacionados |
| EP2285775B1 (en) * | 2008-05-20 | 2017-03-22 | Allergan, Inc. | Lactams and their use in the treatment of inter alia ocular hypertension or baldness |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003008377A1 (en) * | 2001-07-16 | 2003-01-30 | F. Hoffmann-La Roche Ag | Prostaglandin analogues_as ep4 receptor agonists |
| CA2466517A1 (en) * | 2001-11-05 | 2003-05-15 | Allergan, Inc. | .omega.-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| NZ535024A (en) * | 2002-03-05 | 2006-10-27 | Ono Pharmaceutical Co | 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| CA2483555A1 (en) * | 2002-06-10 | 2003-12-18 | Applied Research Systems Ars Holding N.V. | Gamma lactams as prostaglandin agonists and use thereof |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| RU2412933C2 (ru) | 2005-03-10 | 2011-02-27 | Аллерган, Инк. | Замещенные гамма-лактамы в качестве терапевтических агентов |
| EP1996546B1 (en) | 2006-03-20 | 2014-11-26 | Allergan, Inc. | Substituted gamma lactams as prostaglandin ep2 agonists |
-
2008
- 2008-01-29 CN CN200880003507.5A patent/CN101595106B/zh not_active Expired - Fee Related
- 2008-01-29 JP JP2009548391A patent/JP5566692B2/ja not_active Expired - Fee Related
- 2008-01-29 CA CA2676291A patent/CA2676291C/en not_active Expired - Fee Related
- 2008-01-29 EP EP08728470.9A patent/EP2121672B1/en not_active Not-in-force
- 2008-01-29 BR BRPI0808377A patent/BRPI0808377B8/pt not_active IP Right Cessation
- 2008-01-29 AU AU2008210559A patent/AU2008210559B2/en not_active Ceased
- 2008-01-29 MX MX2009008039A patent/MX2009008039A/es active IP Right Grant
- 2008-01-29 WO PCT/US2008/052318 patent/WO2008094912A2/en not_active Ceased
- 2008-01-29 KR KR1020097017970A patent/KR101561706B1/ko not_active Expired - Fee Related
- 2008-01-29 US US12/524,803 patent/US7960381B2/en active Active
- 2008-01-29 NZ NZ578698A patent/NZ578698A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006098918B1 (en) | Substituted gamma lactams as therapeutic agents | |
| JP2010516817A5 (enExample) | ||
| JP2010524932A5 (enExample) | ||
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2005112864A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2007533740A5 (enExample) | ||
| JP2011509309A5 (enExample) | ||
| JP2011504903A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2011516511A5 (enExample) | ||
| JP2007517846A5 (enExample) | ||
| JP2005539088A5 (enExample) | ||
| JP2014521744A5 (enExample) | ||
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| JP2010523476A5 (enExample) | ||
| JP2009543795A5 (enExample) | ||
| JP2007302689A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| JP2011512412A5 (enExample) | ||
| JP2013500342A5 (enExample) | ||
| JP2017511368A5 (enExample) | ||
| JP2014505723A5 (enExample) | ||
| JP2009540009A5 (enExample) | ||
| JP2011509302A5 (enExample) |